Clinical Trial Update: Efficacy, Safety and Tolerability of Repeated Dosis of Intravitreous Bevacizumab in Uveitic Macular Oedema [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating repeated intravitreal bevacizumab for uveitic macular edema was terminated; the update summarizes its efficacy, safety and tolerabili…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Uveitis | Phase 3 | Status: TERMINATED